Eintrag weiter verarbeiten
Ruxolitinib is effective in the treatment of a patient with refractory T-ALL
Gespeichert in:
| Veröffentlicht in: | eJHaem 2(2021), 1, Seite 139-142 |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , |
| Titel: | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL/ Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk |
| Format: | E-Book-Kapitel |
| Sprache: | Englisch |
| veröffentlicht: |
2021
|
| Gesamtaufnahme: |
: eJHaem, 2(2021), 1, Seite 139-142
, volume:2 |
| Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
| LEADER | 04937caa a2200949 4500 | ||
|---|---|---|---|
| 001 | 0-1769525068 | ||
| 003 | DE-627 | ||
| 005 | 20220208214740.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210907s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jha2.143 |2 doi | |
| 035 | |a (DE-627)1769525068 | ||
| 035 | |a (DE-599)KXP1769525068 | ||
| 035 | |a (OCoLC)1295679004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jaramillo Segura, Sonia |e VerfasserIn |0 (DE-588)1149855606 |0 (DE-627)1010162772 |0 (DE-576)496412213 |4 aut | |
| 245 | 1 | 0 | |a Ruxolitinib is effective in the treatment of a patient with refractory T-ALL |c Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk |
| 264 | 1 | |c 2021 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 04 December 2020 | ||
| 500 | |a Gesehen am 07.09.2021 | ||
| 520 | |a T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive T-cell malignancy. Chemotherapy alone cures only 25-45% of the cases, thus, novel treatment agents and strategies are urgently needed. We assessed the efficacy of ruxolitinib in a patient with a cutaneous relapse after allogeneic blood cell transplantation of a refractory T-ALL with a Janus kinase 3 (JAK3) mutation. In this case report, we were able to show the potential benefit of the JAK inhibitor ruxolitinib in JAK3-mutated refractory T-ALL and emphasize the importance of integrating molecular markers in current treatment decision making for patients with T-ALL. | ||
| 700 | 1 | |a Hennemann, Hannah Mai |e VerfasserIn |0 (DE-588)1214672329 |0 (DE-627)1725692104 |4 aut | |
| 700 | 1 | |a Horak, Peter |e VerfasserIn |0 (DE-588)1156426111 |0 (DE-627)1019252839 |0 (DE-576)502179961 |4 aut | |
| 700 | 1 | |a Teleanu, Maria-Veronica |d 1977- |e VerfasserIn |0 (DE-588)1136788557 |0 (DE-627)893574074 |0 (DE-576)49028566X |4 aut | |
| 700 | 1 | |a Heilig, Christoph E. |d 1981- |e VerfasserIn |0 (DE-588)141951141 |0 (DE-627)632539798 |0 (DE-576)325796440 |4 aut | |
| 700 | 1 | |a Hutter, Barbara |e VerfasserIn |0 (DE-588)14009752X |0 (DE-627)61602293X |0 (DE-576)314588760 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 700 | 1 | |a Glimm, Hanno |d 1967- |e VerfasserIn |0 (DE-588)113880677 |0 (DE-627)51985120X |0 (DE-576)289777879 |4 aut | |
| 700 | 1 | |a Goeppert, Benjamin |d 1977- |e VerfasserIn |0 (DE-588)1022581635 |0 (DE-627)717004244 |0 (DE-576)365641324 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Fröhling, Stefan |d 1969- |e VerfasserIn |0 (DE-588)120890046 |0 (DE-627)080950302 |0 (DE-576)188733930 |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 700 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t eJHaem |d Hoboken, NJ : Wiley, 2020 |g 2(2021), 1, Seite 139-142 |h Online-Ressource |w (DE-627)1698060459 |w (DE-600)3021452-X |x 2688-6146 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2021 |g number:1 |g pages:139-142 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/jha2.143 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/jha2.143 |x Verlag |z kostenfrei |3 Volltext |
| 936 | u | w | |d 2 |j 2021 |e 1 |h 139-142 |g 4 |
| 951 | |a AR | ||
| 856 | 4 | 0 | |u https://doi.org/10.1002/jha2.143 |9 LFER |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/jha2.143 |9 LFER |
| 852 | |a LFER |z 2021-10-06T11:27:50Z | ||
| 970 | |c OD | ||
| 971 | |c EBOOK | ||
| 972 | |c EBOOK | ||
| 973 | |c Aufsatz | ||
| 935 | |a lfer | ||
| 900 | |a Glimm, H. | ||
| 900 | |a Stenzinger, A. | ||
| 900 | |a Teleanu, Maria Veronica | ||
| 900 | |a Teleanu, Veronica | ||
| 900 | |a Tidow, Carsten Müller- | ||
| 900 | |a Mueller-Tidow, Carsten | ||
| 900 | |a Heilig, Christoph Emanuel | ||
| 900 | |a Heilig, Christoph | ||
| 900 | |a Goeppert, Frank Benjamin | ||
| 900 | |a Goeppert, B. | ||
| 900 | |a Göppert, Benjamin | ||
| 900 | |a Schoenland, Stefan | ||
| 900 | |a Schönland, Stefan O. | ||
| 900 | |a Schönland, Stefan Olaf | ||
| 900 | |a Schonland, Stefan | ||
| 900 | |a Schönland, S. | ||
| 900 | |a Schönland, S. O. | ||
| 900 | |a Schonland, Stefan O. | ||
| 900 | |a Hennemann, Hannah M. | ||
| 900 | |a Hennemann, Hannah | ||
| 900 | |a Hennemann, H. M. | ||
| 900 | |a Schlenk, Richard F. | ||
| 900 | |a Schlenk, R. F. | ||
| 900 | |a Schlenk, Richard | ||
| 900 | |a Jaramillo-Segura, Sonia | ||
| 900 | |a Segura, Sonia Jaramillo- | ||
| 900 | |a Jaramillo, Sonia | ||
| 951 | |b XA-DE | ||
| 951 | |b XD-CO | ||
| 980 | |a 1769525068 |b 0 |k 1769525068 |c lfer | ||
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Ruxolitinib+is+effective+in+the+treatment+of+a+patient+with+refractory+T-ALL&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Jaramillo+Segura%2C+Sonia&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=2688-6146 |
|---|
| _version_ | 1757972359494500352 |
|---|---|
| access_facet | Electronic Resources |
| author | Jaramillo Segura, Sonia, Hennemann, Hannah Mai, Horak, Peter, Teleanu, Maria-Veronica, Heilig, Christoph E., Hutter, Barbara, Stenzinger, Albrecht, Glimm, Hanno, Goeppert, Benjamin, Müller-Tidow, Carsten, Fröhling, Stefan, Schönland, Stefan, Schlenk, Richard Friedrich |
| author_facet | Jaramillo Segura, Sonia, Hennemann, Hannah Mai, Horak, Peter, Teleanu, Maria-Veronica, Heilig, Christoph E., Hutter, Barbara, Stenzinger, Albrecht, Glimm, Hanno, Goeppert, Benjamin, Müller-Tidow, Carsten, Fröhling, Stefan, Schönland, Stefan, Schlenk, Richard Friedrich |
| author_role | aut, aut, aut, aut, aut, aut, aut, aut, aut, aut, aut, aut, aut |
| author_sort | Jaramillo Segura, Sonia |
| author_variant | s s j ss ssj, h m h hm hmh, p h ph, m v t mvt, c e h ce ceh, b h bh, a s as, h g hg, b g bg, c m t cmt, s f sf, s s ss, r f s rf rfs |
| callnumber-sort | |
| collection | lfer |
| container_reference | 2(2021), 1, Seite 139-142 |
| container_title | eJHaem |
| contents | T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive T-cell malignancy. Chemotherapy alone cures only 25-45% of the cases, thus, novel treatment agents and strategies are urgently needed. We assessed the efficacy of ruxolitinib in a patient with a cutaneous relapse after allogeneic blood cell transplantation of a refractory T-ALL with a Janus kinase 3 (JAK3) mutation. In this case report, we were able to show the potential benefit of the JAK inhibitor ruxolitinib in JAK3-mutated refractory T-ALL and emphasize the importance of integrating molecular markers in current treatment decision making for patients with T-ALL. |
| ctrlnum | (DE-627)1769525068, (DE-599)KXP1769525068, (OCoLC)1295679004 |
| doi_str_mv | 10.1002/jha2.143 |
| facet_avail | Online, Free |
| finc_class_facet | not assigned |
| footnote | First published: 04 December 2020, Gesehen am 07.09.2021 |
| format | ElectronicBookComponentPart |
| format_access_txtF_mv | Article, E-Article |
| format_de105 | Ebook |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_del152 | Buch |
| format_detail_txtF_mv | text-online-monograph-child |
| format_dezi4 | e-Book |
| format_finc | Article, E-Article |
| format_legacy | ElectronicBookPart |
| format_strict_txtF_mv | E-Article |
| geogr_code | not assigned |
| geogr_code_person | Germany, Colombia |
| hierarchy_parent_id | 0-1698060459 |
| hierarchy_parent_title | eJHaem |
| hierarchy_sequence | 2(2021), 1, Seite 139-142 |
| hierarchy_top_id | 0-1698060459 |
| hierarchy_top_title | eJHaem |
| id | 0-1769525068 |
| illustrated | Not Illustrated |
| imprint | 2021 |
| imprint_str_mv | 2021 |
| institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
| is_hierarchy_id | 0-1769525068 |
| is_hierarchy_title | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL |
| isil_str_mv | LFER |
| issn | 2688-6146 |
| kxp_id_str | 1769525068 |
| language | English |
| last_indexed | 2023-02-16T07:38:07.106Z |
| marc024a_ct_mv | 10.1002/jha2.143 |
| match_str | jaramillosegura2021ruxolitinibiseffectiveinthetreatmentofapatientwithrefractorytall |
| mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
| misc_de105 | EBOOK |
| multipart_link | (DE-600)3021452-X |
| multipart_part | ((DE-600)3021452-X)2(2021), 1, Seite 139-142 |
| names_id_str_mv | (DE-588)1149855606, (DE-627)1010162772, (DE-576)496412213, (DE-588)1214672329, (DE-627)1725692104, (DE-588)1156426111, (DE-627)1019252839, (DE-576)502179961, (DE-588)1136788557, (DE-627)893574074, (DE-576)49028566X, (DE-588)141951141, (DE-627)632539798, (DE-576)325796440, (DE-588)14009752X, (DE-627)61602293X, (DE-576)314588760, (DE-588)139606106, (DE-627)703395238, (DE-576)312432755, (DE-588)113880677, (DE-627)51985120X, (DE-576)289777879, (DE-588)1022581635, (DE-627)717004244, (DE-576)365641324, (DE-588)1015101798, (DE-627)705330230, (DE-576)351197893, (DE-588)120890046, (DE-627)080950302, (DE-576)188733930, (DE-588)122405226, (DE-627)705896137, (DE-576)293255792, (DE-588)129025380, (DE-627)387778004, (DE-576)297454102 |
| oclc_num | 1295679004 |
| physical | 4 |
| publishDate | 2021 |
| publishDateSort | 2021 |
| publishPlace | |
| publisher | |
| record_format | marcfinc |
| record_id | 1769525068 |
| recordtype | marcfinc |
| rvk_facet | No subject assigned |
| source_id | 0 |
| spelling | Jaramillo Segura, Sonia VerfasserIn (DE-588)1149855606 (DE-627)1010162772 (DE-576)496412213 aut, Ruxolitinib is effective in the treatment of a patient with refractory T-ALL Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk, 2021, 4, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, First published: 04 December 2020, Gesehen am 07.09.2021, T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive T-cell malignancy. Chemotherapy alone cures only 25-45% of the cases, thus, novel treatment agents and strategies are urgently needed. We assessed the efficacy of ruxolitinib in a patient with a cutaneous relapse after allogeneic blood cell transplantation of a refractory T-ALL with a Janus kinase 3 (JAK3) mutation. In this case report, we were able to show the potential benefit of the JAK inhibitor ruxolitinib in JAK3-mutated refractory T-ALL and emphasize the importance of integrating molecular markers in current treatment decision making for patients with T-ALL., Hennemann, Hannah Mai VerfasserIn (DE-588)1214672329 (DE-627)1725692104 aut, Horak, Peter VerfasserIn (DE-588)1156426111 (DE-627)1019252839 (DE-576)502179961 aut, Teleanu, Maria-Veronica 1977- VerfasserIn (DE-588)1136788557 (DE-627)893574074 (DE-576)49028566X aut, Heilig, Christoph E. 1981- VerfasserIn (DE-588)141951141 (DE-627)632539798 (DE-576)325796440 aut, Hutter, Barbara VerfasserIn (DE-588)14009752X (DE-627)61602293X (DE-576)314588760 aut, Stenzinger, Albrecht VerfasserIn (DE-588)139606106 (DE-627)703395238 (DE-576)312432755 aut, Glimm, Hanno 1967- VerfasserIn (DE-588)113880677 (DE-627)51985120X (DE-576)289777879 aut, Goeppert, Benjamin 1977- VerfasserIn (DE-588)1022581635 (DE-627)717004244 (DE-576)365641324 aut, Müller-Tidow, Carsten VerfasserIn (DE-588)1015101798 (DE-627)705330230 (DE-576)351197893 aut, Fröhling, Stefan 1969- VerfasserIn (DE-588)120890046 (DE-627)080950302 (DE-576)188733930 aut, Schönland, Stefan 1969- VerfasserIn (DE-588)122405226 (DE-627)705896137 (DE-576)293255792 aut, Schlenk, Richard Friedrich 1965- VerfasserIn (DE-588)129025380 (DE-627)387778004 (DE-576)297454102 aut, Enthalten in eJHaem Hoboken, NJ : Wiley, 2020 2(2021), 1, Seite 139-142 Online-Ressource (DE-627)1698060459 (DE-600)3021452-X 2688-6146 nnns, volume:2 year:2021 number:1 pages:139-142 extent:4, https://doi.org/10.1002/jha2.143 Verlag Resolving-System kostenfrei Volltext, https://onlinelibrary.wiley.com/doi/abs/10.1002/jha2.143 Verlag kostenfrei Volltext, https://doi.org/10.1002/jha2.143 LFER, https://onlinelibrary.wiley.com/doi/abs/10.1002/jha2.143 LFER, LFER 2021-10-06T11:27:50Z |
| spellingShingle | Jaramillo Segura, Sonia, Hennemann, Hannah Mai, Horak, Peter, Teleanu, Maria-Veronica, Heilig, Christoph E., Hutter, Barbara, Stenzinger, Albrecht, Glimm, Hanno, Goeppert, Benjamin, Müller-Tidow, Carsten, Fröhling, Stefan, Schönland, Stefan, Schlenk, Richard Friedrich, Ruxolitinib is effective in the treatment of a patient with refractory T-ALL, T-cell acute lymphoblastic leukemia (T-ALL) is a rare, aggressive T-cell malignancy. Chemotherapy alone cures only 25-45% of the cases, thus, novel treatment agents and strategies are urgently needed. We assessed the efficacy of ruxolitinib in a patient with a cutaneous relapse after allogeneic blood cell transplantation of a refractory T-ALL with a Janus kinase 3 (JAK3) mutation. In this case report, we were able to show the potential benefit of the JAK inhibitor ruxolitinib in JAK3-mutated refractory T-ALL and emphasize the importance of integrating molecular markers in current treatment decision making for patients with T-ALL. |
| title | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL |
| title_auth | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL |
| title_full | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk |
| title_fullStr | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk |
| title_full_unstemmed | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk |
| title_in_hierarchy | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL / Sonia Jaramillo, Hannah Hennemann, Peter Horak, Veronica Teleanu, Christoph E. Heilig, Barbara Hutter, Albrecht Stenzinger, Hanno Glimm, Benjamin Goeppert, Carsten Müller-Tidow, Stefan Fröhling, Stefan Schönland, Richard F. Schlenk, |
| title_short | Ruxolitinib is effective in the treatment of a patient with refractory T-ALL |
| title_sort | ruxolitinib is effective in the treatment of a patient with refractory t all |
| url | https://doi.org/10.1002/jha2.143, https://onlinelibrary.wiley.com/doi/abs/10.1002/jha2.143 |